Literature DB >> 8027318

Comparison of novel synthetic peptide-based DETECT-RUBELLA enzyme immunoassays with Enzygnost and IMx for detection of rubella-specific immunoglobulin G.

L Pedneault1, M Zrein, L Robillard, F Landry, M Lacroix, J Joncas.   

Abstract

Enzyme immunoassays (EIAs) using synthetic peptides SP-E1 and SP-E1E2 (DETECT-RUBELLA [Bio-Chem]) were compared with two viral lysate-based EIAs (Enzygnost [Behring] and IMx [Abbott]) for the detection of rubella virus-specific immunoglobulin G antibodies. Sensitivities of 94.7, 100, 98.6, and 100% and specificities of 100, 97.4, 100, and 73.7% were found for the SP-E1, SP-E1E2, Enzygnost, and IMx EIAs, respectively.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8027318      PMCID： PMC267191          DOI： 10.1128/jcm.32.4.1085-1087.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis.

Authors:  L Lozzi; M Rustici; M Corti; M G Cusi; P E Valensin; L Bracci; A Santucci; P Soldani; A Spreafico; P Neri
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies.

Authors:  K Y Green; P H Dorsett
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  E1 glycoprotein of rubella virus carries an epitope that binds a neutralizing antibody.

Authors:  M Trudel; F Nadon; C Séguin; A Amarouch; P Payment; S Gillam
Journal:  J Virol Methods       Date:  1985-12       Impact factor: 2.014

4.  Development of automated immunoassays for immune status screening and serodiagnosis of rubella virus infection.

Authors:  G G Abbott; J W Safford; R G MacDonald; M C Craine; R R Applegren
Journal:  J Virol Methods       Date:  1990-02       Impact factor: 2.014

5.  Localization of the rubella E1 epitopes.

Authors:  G M Terry; L Ho-Terry; P Londesborough; K R Rees
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

6.  Monoclonal antibody-defined epitope map of expressed rubella virus protein domains.

Authors:  J S Wolinsky; M McCarthy; O Allen-Cannady; W T Moore; R Jin; S N Cao; A Lovett; D Simmons
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

7.  Available rubella serologic tests.

Authors:  K L Herrmann
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

8.  Comparison of a whole-virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination.

Authors:  M Zrein; J H Joncas; L Pedneault; L Robillard; R J Dwyer; M Lacroix
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

9.  Antibody response to individual rubella virus proteins in congenital and other rubella virus infections.

Authors:  S Katow; A Sugiura
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

10.  Rubella-specific IgG subclass concentrations in sera using an enzyme-linked immunosorbent assay (ELISA): the effect of different sources of rubella antigen.

Authors:  H I Thomas; P Morgan-Capner
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451
View more
  2 in total

1.  Evaluation of Cobas Core Rubella IgG EIA recomb, a new enzyme immunoassay based on recombinant rubella-like particles.

Authors:  L Grangeot-Keros; B Pustowoit; T Hobman
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

2.  Epidemiology of rubella infections in Austria: important lessons to be learned.

Authors:  B Falkensammer; G Walder; D Busch; A Giessauf; M Dierich; R Würzner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-18       Impact factor: 5.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.